about
Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates.Glioma and glioblastoma - how much do we (not) know?Sequencing the next generation of glioblastomas.Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting.Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy.Genetic secrets of long-term glioblastoma survivorsThe Therapeutic Potential of NanobodiesHigh FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT GlioblastomasNanomedicine and Immunotherapy: A Step Further towards Precision Medicine for GlioblastomaAnti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
P50
Q36370196-7D592BB3-0C06-49A6-8F6D-28978346484BQ42578340-1E93055C-F41B-4F37-9DF3-81C41F699983Q52580778-978F139E-BFC6-460D-99F4-51AB19619D94Q54965858-8D6D0E42-9DF4-44D1-9C01-326034F9C2FFQ64956054-DB19D5D3-F07A-4216-832B-A6117E2C9C63Q90980641-9AAFC264-BE30-4238-A342-99A1DB3C160CQ91108912-D110C081-C7B2-4005-B056-02C8922E4A1BQ92257746-0119E017-F6F1-4C01-B4DC-AB8F8266796BQ92923739-C7AB689A-81B5-4C3D-866E-C86BCDC3B93BQ95273152-FCFF3414-6D16-4559-A0D0-B56E3D057988
P50
description
investigador
@es
researcher
@en
name
Ivana Jovčevska
@en
type
label
Ivana Jovčevska
@en
prefLabel
Ivana Jovčevska
@en
P31
P496
0000-0002-0418-2986